Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3461)
Kura Oncology, Inc. (KURA)
Bair Teresa Brophy — Chief Legal Officer
Shares
2,256
Price
$9.38
Total Value
$21.16K
Shares Held After
226,931
% of Holdings
1.0%
CNS Pharmaceuticals, Inc. (CNSP)
Charles Faith L. — Director
Shares
7,100
Price
$4.79
Total Value
$34.00K
Shares Held After
7,100
% of Holdings
100.0%
Orchestra BioMed Holdings, Inc. (OBIO)
Aryeh Jason — Director
Shares
665
Price
$3.75
Total Value
$2.49K
Shares Held After
118,118
% of Holdings
0.6%
BIOCRYST PHARMACEUTICALS INC (BCRX)
McKee Amy E — Director
Shares
11,180
Price
$8.97
Total Value
$100.28K
Shares Held After
31,252
% of Holdings
26.3%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
50,000
Price
$19.00
Total Value
$949.76K
Shares Held After
1,122,626
% of Holdings
4.3%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
417
Price
$27.55
Total Value
$11.49K
Shares Held After
63,443
% of Holdings
0.7%
Tenaya Therapeutics, Inc. (TNYA)
Higa Tomohiro — SVP, Finance
Shares
1,485
Price
$0.79
Total Value
$1.18K
Shares Held After
118,267
% of Holdings
1.2%
Tenaya Therapeutics, Inc. (TNYA)
Tingley Whittemore — Chief Medical Officer
Shares
3,121
Price
$0.79
Total Value
$2.48K
Shares Held After
215,497
% of Holdings
1.4%
EXELIXIS, INC. (EXEL)
Senner Christopher J. — EVP and CFO
Shares
34,901
Price
$50.00
Total Value
$1.75M
Shares Held After
952,317
% of Holdings
3.5%
EXELIXIS, INC. (EXEL)
Hefti Brenda — SVP and General Counsel
Shares
6,625
Price
$50.21
Total Value
$332.64K
Shares Held After
106,762
% of Holdings
5.8%
Tenaya Therapeutics, Inc. (TNYA)
Ali Faraz — Director
Shares
3,390
Price
$0.79
Total Value
$2.69K
Shares Held After
440,014
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$570.18
Total Value
$22.81K
Shares Held After
18,876
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,322
Price
$569.56
Total Value
$752.96K
Shares Held After
18,916
% of Holdings
6.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,304
Price
$568.43
Total Value
$741.23K
Shares Held After
20,238
% of Holdings
6.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,785
Price
$568.48
Total Value
$1.58M
Shares Held After
21,542
% of Holdings
11.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,796
Price
$566.39
Total Value
$1.02M
Shares Held After
24,327
% of Holdings
6.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,131
Price
$565.44
Total Value
$1.20M
Shares Held After
26,123
% of Holdings
7.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
422
Price
$564.30
Total Value
$238.14K
Shares Held After
28,254
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
200
Price
$562.91
Total Value
$112.58K
Shares Held After
28,676
% of Holdings
0.7%
BridgeBio Pharma, Inc. (BBIO)
Trimarchi Thomas — President and CFO
Shares
3,195
Price
$65.95
Total Value
$210.71K
Shares Held After
359,194
% of Holdings
0.9%
BridgeBio Pharma, Inc. (BBIO)
Trimarchi Thomas — President and CFO
Shares
10,456
Price
$64.82
Total Value
$677.71K
Shares Held After
362,389
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$569.99
Total Value
$159.60K
Shares Held After
40,513
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,077
Price
$569.42
Total Value
$613.26K
Shares Held After
40,793
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,437
Price
$568.33
Total Value
$816.69K
Shares Held After
41,870
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,280
Price
$567.45
Total Value
$1.29M
Shares Held After
43,307
% of Holdings
5.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,117
Price
$566.33
Total Value
$1.20M
Shares Held After
45,587
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,811
Price
$565.34
Total Value
$1.02M
Shares Held After
47,704
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
365
Price
$564.11
Total Value
$205.90K
Shares Held After
49,515
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
133
Price
$563.01
Total Value
$74.88K
Shares Held After
49,880
% of Holdings
0.3%
KalVista Pharmaceuticals, Inc. (KALV)
Yea Christopher — CHIEF DEVELOPMENT OFFICER
Shares
1,108
Price
$26.76
Total Value
$29.65K
Shares Held After
227,367
% of Holdings
0.5%
Seres Therapeutics, Inc. (MCRB)
Brady Kelly — Chief Operating Officer, EVP
Shares
59
Price
$7.53
Total Value
$444.27
Shares Held After
8,562
% of Holdings
0.7%
Seres Therapeutics, Inc. (MCRB)
Henn Matthew R — Chief Scientific Officer and EVP
Shares
77
Price
$7.53
Total Value
$579.81
Shares Held After
7,838
% of Holdings
1.0%
Seres Therapeutics, Inc. (MCRB)
Shaff Eric D. — Director
Shares
259
Price
$7.53
Total Value
$1.95K
Shares Held After
12,040
% of Holdings
2.1%
Seres Therapeutics, Inc. (MCRB)
DesRosier Thomas — EVP and Chief Legal Officer
Shares
79
Price
$7.53
Total Value
$594.87
Shares Held After
7,954
% of Holdings
1.0%
KalVista Pharmaceuticals, Inc. (KALV)
Audhya Paul K. — CHIEF MEDICAL OFFICER
Shares
1,032
Price
$26.76
Total Value
$27.62K
Shares Held After
143,934
% of Holdings
0.7%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
1,129
Price
$26.76
Total Value
$30.21K
Shares Held After
467,665
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
198
Price
$28.15
Total Value
$5.57K
Shares Held After
1,394,094
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
118,037
Price
$27.19
Total Value
$3.21M
Shares Held After
1,394,292
% of Holdings
7.8%
Zenas BioPharma, Inc. (ZBIO)
MOULDER LEON O JR — Director
Shares
60,000
Price
$16.88
Total Value
$1.01M
Shares Held After
96,928
% of Holdings
61.9%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,700
Price
$0.92
Total Value
$5.24K
Shares Held After
291,566
% of Holdings
2.0%
Ultragenyx Pharmaceutical Inc. (RARE)
SULIMAN SHEHNAAZ — Director
Shares
5,740
Price
$25.12
Total Value
$144.19K
Shares Held After
27,951
% of Holdings
17.0%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
700
Price
$61.16
Total Value
$42.81K
Shares Held After
16,406
% of Holdings
4.1%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
800
Price
$60.34
Total Value
$48.27K
Shares Held After
17,106
% of Holdings
4.5%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
4,600
Price
$59.19
Total Value
$272.26K
Shares Held After
17,906
% of Holdings
20.4%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
4,190
Price
$58.34
Total Value
$244.47K
Shares Held After
22,506
% of Holdings
15.7%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Soergel David — Chief Medical Officer
Shares
844
Price
$515.90
Total Value
$435.42K
Shares Held After
11,075
% of Holdings
7.1%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
3,000
Price
$18.76
Total Value
$56.28K
Shares Held After
3,622
% of Holdings
45.3%
Keros Therapeutics, Inc. (KROS)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$10.58
Total Value
$10.58K
Shares Held After
9,450
% of Holdings
10.6%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
German Christopher Paul — Corporate Controller & CAO
Shares
4,643
Price
$92.21
Total Value
$428.13K
Shares Held After
0
% of Holdings
100.0%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
50,000
Price
$20.74
Total Value
$1.04M
Shares Held After
1,122,626
% of Holdings
4.3%
Showing 751–800 of 3461 transactions (page 16 of 70)